![So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC](https://oncodaily.com/pub/uploads/2023/06/Arun-Azad-1-1280x1280.png)
Photo from Arun Azad/Twitter
Jun 21, 2023, 18:41
So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC
In a post by Arun Azad on Twitter, it says, “So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC. Impressive rPFS & OS data in this population (see Table). A big win for a lot of pts as approx. 25% of 1L mCRPC pts are HRR-deficient.”
Source: Arun Azad/Twitter